Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (272 million pounds) spanning five years because of Washington's demand for sensitive data.
The decision became public following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government representative has since explained that the US was seeking health data for scientific study and commercial gain while was unwilling to share the resulting advantages from any future vaccines.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged further negotiations to secure a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision follows a comparable case in Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
Since resuming the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government agreements to boost transparency and accountability.
Based on statements, Sixteen African countries have so far agreed to similar health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"In essence, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be available to our people should a new disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending structures already set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This framework is designed to ensure that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how subsequent collaboration might be arranged in a manner that honours the independence and dignity of both nations."
Health Experts Response
Medical experts stated it recognised the government's concerns, but suggested that negotiations need to persist since a large portion of the country's HIV programmes relied on foreign aid.
"Where technical issues arise, including those relating to information security or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," the group added.
The situation underscores the complex challenges between receiving crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.